16627933|t|The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
16627933|a|It is largely unknown why some patients with Alzheimer's disease (AD) decline cognitively more rapidly than others. Genetic differences among patients could influence rate of decline. Brain-derived neurotrophic factor (BDNF) is a neurotrophin important in the survival neurons and in memory function. BDNF levels are reduced in the brain in AD. The Val66Met polymorphism in the BDNF gene modifies neuronal BDNF secretion, and affects hippocampal function and memory performance. We tested the hypothesis that the BDNF Val66Met polymorphism influences rate of cognitive decline in AD. In a sample of 149 AD patients followed for an average of 3.9 years, we found no effect of BDNF Val66Met genotype on rate of change in the Mini Mental State Examination. Results were similar when we excluded patients taking an acetylcholinesterase inhibitor, those placed in a nursing home during the study, or those with a neuropathological diagnosis that included AD plus an entity other than AD. We also found no evidence that the effects of the BDNF Val66Met genotype depend on APOE genotype, which itself had no effect on rate of cognitive change. These findings suggest that the functional BDNF Val66Met variant is not a major determinant of rate of cognitive decline in AD.
16627933	4	37	brain-derived neurotrophic factor	Gene	627
16627933	38	46	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	83	102	Alzheimer's disease	Disease	MESH:D000544
16627933	135	143	patients	Species	9606
16627933	149	168	Alzheimer's disease	Disease	MESH:D000544
16627933	170	172	AD	Disease	MESH:D000544
16627933	246	254	patients	Species	9606
16627933	288	321	Brain-derived neurotrophic factor	Gene	627
16627933	323	327	BDNF	Gene	627
16627933	405	409	BDNF	Gene	627
16627933	445	447	AD	Disease	MESH:D000544
16627933	453	461	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	482	486	BDNF	Gene	627
16627933	510	514	BDNF	Gene	627
16627933	617	621	BDNF	Gene	627
16627933	622	630	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	663	680	cognitive decline	Disease	MESH:D003072
16627933	684	686	AD	Disease	MESH:D000544
16627933	707	709	AD	Disease	MESH:D000544
16627933	710	718	patients	Species	9606
16627933	779	783	BDNF	Gene	627
16627933	784	792	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	896	904	patients	Species	9606
16627933	1054	1056	AD	Disease	MESH:D000544
16627933	1083	1085	AD	Disease	MESH:D000544
16627933	1137	1141	BDNF	Gene	627
16627933	1142	1150	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	1170	1174	APOE	Gene	348
16627933	1284	1288	BDNF	Gene	627
16627933	1289	1297	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
16627933	1344	1361	cognitive decline	Disease	MESH:D003072
16627933	1365	1367	AD	Disease	MESH:D000544

